Prostate cancer is the common cancer among men in Nigeria and Ghana. According to GLOBOCAN 2022. The global cancer database from the International Agency for Research on Cancer which operates under the World Health Organization. Prostate cancer makes up 29% of all new male cancer cases in Nigeria. The same pattern is seen in Ghana, where prostate cancer also holds a leading position. Yet many men in West Africa are diagnosed in the late stages. This happens because prostate-specific antigen or PSA screening is not widely available. Also awareness about signs of prostate cancer is still low.
India provides a affordable and high-quality option for men in Nigeria and Ghana who are dealing with prostate cancer. Whether it is early-stage disease requiring surgery or advanced castration-resistant cases needing complex treatments India offers effective care. This guide walks through all treatment options, including the costs involved expected outcomes and how patients, from West Africa can begin their journey to care in India.
Prostate Cancer in Nigeria and Ghana — Why Late Diagnosis Is Common
Prostate cancer is the common cancer among men in Nigeria and Ghana. According to GLOBOCAN 2022. The global cancer database from the International Agency for Research on Cancer which operates under the World Health Organization. Prostate cancer makes up 29% of all new male cancer cases in Nigeria. The same pattern is seen in Ghana, where prostate cancer also holds a leading position. Yet many men in West Africa are diagnosed in the late stages. This happens because prostate-specific antigen or PSA screening is not widely available. Also, awareness about signs of prostate cancer is still low.
India provides an affordable and high-quality option for men in Nigeria and Ghana who are dealing with prostate cancer. Whether it is early-stage disease requiring surgery or advanced castration-resistant cases needing complex treatments, India offers effective care. This guide walks through all treatment options, including the costs involved, expected outcomes, and how patients from West Africa can begin their journey to care in India.
Understanding Your Diagnosis — PSA, Gleason Score, and Stage
PSA Level — What the Numbers Mean
- PSA below 4 ng/mL: normal, although aggressive cancers can still arise when PSA is low.
- PSA 4–10 ng/mL: borderline – a biopsy is often recommended.
- PSA, above 10 ng/mL: PSA – a biopsy is strongly recommended.
- PSA above 100 ng/mL: high PSA – usually means metastatic disease.
Gleason Score — Understanding Your Biopsy Result
The Gleason score grades prostate cancer aggressiveness from 6 which is the least aggressive, to 10 which is the most aggressive, based on the biopsy specimen. A Gleason 6 result means risk and is suitable, for active surveillance or local treatment. A Gleason 7 result, whether 3+4 or 4+3 means risk and is usually treated. A Gleason 8 to 10 result means high risk and systemic therapy is often combined with treatment.
Prostate Cancer Treatment Options in India — By Stage
Early-Stage (Localised) Prostate Cancer — Stage T1–T2
If you or someone you know has localised prostate cancer (cancer confined to the prostate gland) I have seen that India offers two curative treatment options. Radical prostatectomy and radiation therapy. The outcomes from India are comparable to those, from the world’s leading cancer centres.
Robotic-Assisted Radical Prostatectomy (RARP)
Da Vinci robotic-assisted laparoscopic prostatectomy is available at BLK-Max, Fortis Memorial and Apollo Hospitals in Delhi. The robotic method provides accuracy than traditional surgery. The main benefits include:
- less blood loss and fewer need for blood transfusions
- Faster recovery. Most people leave the hospital after 3 or 4 days
- Better keeping of urinary control and sexual function (using a nerve-sparing technique)
- Cancer results similar to open surgery for the right type of cases
- Cost in India: 4,500 to 7,000 dollars (compared to 15,000 to 25,000 dollars in South Africa private and 30,000 to 50,000 dollars, in USA
Radiation Therapy — IMRT and Stereotactic Body Radiation (SBRT)
For patients who choose radiation of surgery or for patients who have co‑morbidities that make surgery very risky India’s cancer centres offer:
- IMRT (Intensity‑Modulated Radiation Therapy) uses shaped radiation beams that target the prostate. The treatment lasts about 7 to 8 weeks. Cost: $4,000–$7,000.
- SBRT (Stereotactic Body Radiation / CyberKnife) delivers high‑dose, targeted radiation in only 4 to 5 sessions. The results are similar to IMRT. The treatment course is shorter. This option is available, at Fortis Memorial and BLK‑ Cost: $5,000–$8,000.
- Brachytherapy places seeds directly in the prostate. It is often used for disease. Cost: $5,000–$7,000.
Intermediate and High-Risk Localised Prostate Cancer
When a patient has Gleason 7–10 disease or Stage T3 meaning the cancer has begun to spread beyond the prostate doctors in India usually follow guidelines. They may choose to perform a prostatectomy, which includes removing nearby lymph nodes or they may opt for radiation therapy combined with androgen deprivation therapy or ADT. ADT is a hormone therapy that reduces testosterone the fuel that helps prostate cancer grow. The time that patients receive ADT depends on their risk level: six months for risk and two to three years, for high risk.
Metastatic Prostate Cancer — Options in India
I know that for patients with bone or lymph metastases, at diagnosis curative treatment is not possible.. India offers very good therapies that can extend life for patients.
- I have seen that Androgen Deprivation Therapy (ADT) uses Leuprolide or degarelix injections plus bicalutamide. I have seen that Androgen Deprivation Therapy (ADT) costs in India are significantly lower than costs in pharmacies in Africa.
- I have seen that Docetaxel chemotherapy is used for volume metastatic disease at the outset. I have seen that Docetaxel chemotherapy is available at every Indian cancer centre. I have seen that Docetaxel chemotherapy costs between $800 and $1,500, per cycle.
- Novel hormonal agents, Enzalutamide and Abiraterone are game‑changing drugs for prostate cancer. I have learned that these drugs are available as generics in India and the cost is dramatically lower than branded versions.
- PSMA‑targeted radionuclide therapy, PSMA can be found at selected centres, including Tata Memorial for patients, with PSMA‑positive castration‑resistant disease.
Prostate Cancer Treatment Cost in India for Nigerian and Ghanaian Patients
| Treatment | India Cost | South Africa(Private) | UK | Locally Available in Nigeria/Ghana |
|---|---|---|---|---|
| Robotic Prostatectomy (RARP) | $4,500–$7,000 | $15,000–$25,000 | $30,000–$50,000 | Very limited |
| IMRT Radiation (full course) | $4,000–$7,000 | $12,000–$20,000 | $20,000 $25,000–$40,000 | Very limited |
| SBRT / CyberKnife (5 sessions) | $5,000–$8,000 | $15,000–$25,000 | $30,000+ | Not available |
| ADT (Leuprolide injection/3 months) | $150–$300 | $800–$1,500 | $1,000–$2,000 | Available, costly |
| Docetaxel chemo (per cycle) | $800–$1,500 | $3,000–$6,000 | $5,000–$10,000 | Available, costly |
| Enzalutamide (month supply — generic) | $300–$600 | $3,000–$5,000 | $4,000–$6,000 | Very limited |
| PSMA PET scan (staging) | $400–$600 | $1,500–$3,000 | $2,000+ | Not available |
How to Start: Sending Your Reports to MediKaya Healthcare
Getting a prostate cancer evaluation from an oncologist does not mean you have to travel to India right away. The full first assessment can be completed from anywhere in the world in 48 hours using WhatsApp.
- Start by collecting your records: your PSA test result with the date the prostate biopsy pathology report showing the Gleason score any imaging results like a CT scan, bone scan or MRI of the pelvis and any records, from past treatments.
- Send these documents to MediKaya Healthcare via WhatsApp at +91 9205491370. Also include your age, your current symptoms and any treatment you have already received.
- MediKaya’s oncology partner will review your case within 48 hours. You will receive a written recommendation that includes the stage assessment, available treatment options, a specific hospital recommendation and a cost estimate.
- If you decide to move MediKaya Healthcare will arrange your medical visa in 3 to 5 days confirm your hospital booking and assign a coordinator to help you.
- Once you arrive in Delhi treatment can begin within 3 to 5 days of your arrival.
Frequently Asked Questions — Prostate Cancer India Nigeria Ghana
Q: My PSA is 28 and the biopsy shows Gleason 3+4. I am 62 years old. What is my treatment option in India?
A: Gleason 3+4 (Grade Group 2) with PSA 28 places this in the intermediate-to-risk localised category. The staging question. Whether cancer has spread beyond the prostate. Depends on MRI pelvis and PSMA PET scan, which MediKaya would arrange on arrival. If localised, both prostatectomy and IMRT+ADT are curative options with equivalent long-term cancer control. At 62 with PSA 28 most centres, in India would offer prostatectomy with nerve-sparing if MRI shows organ-confined disease. MediKaya’s urological oncologist will review your biopsy and any imaging you have.
Q: I am from Lagos and my father has been diagnosed with prostate cancer that has spread to his bones. Is it too late for treatment in India?
A: Metastatic prostate cancer with bone involvement is not curable. It is very treatable and the modern treatments available in India can significantly extend both length and quality of life. ADT combined with agents like Enzalutamide or Abiraterone has dramatically improved outcomes for metastatic prostate cancer. A PSMA PET scan, which is available in India, for $400–$600 would map the extent of disease and guide treatment planning. Please send us your father’s PSA level, biopsy report and any bone scan or CT results.
Q: How long will my husband need to stay in India for robotic prostatectomy?
A: I found that Robotic prostatectomy takes ten to fourteen days in India. That total time includes two to three days for -operative assessment the actual Robotic prostatectomy which lasts three to four hours three to four days in the hospital after the Robotic prostatectomy and three to five days of observation before travel clearance. PSA is checked four to six weeks after the prostatectomy. You can have the PSA test done at any laboratory in Nigeria or Ghana. The result can be sent to MediKaya’s oncologist, via WhatsApp.
Q: Is generic Enzalutamide from India as effective as the branded version?
A: Generic Enzalutamide, the drug that is sold under the brand name Xtandi is made by Indian companies such as Cipla and Sun Pharma. These manufacturers produce the medicine under approval from the CDSCO following rules. Because of the bioequivalence standards Generic Enzalutamide shows the pharmacokinetic profile as the original Xtandi. Generic Enzalutamide is used over the world and it even takes part in programmes that have been approved by the WHO. In India people can get Generic Enzalutamide for $300 to $600 a month whereas the branded Xtandi costs between $4,000 and $6,000, in the United Kingdom.